Why Hims & Hers Health, Inc. (HIMS) Stock Fell 16.5% on Nov 10, 2026
as of Tuesday, 4:48 PM ET
The reason we found
Earnings miss and weaker outlook trigger Hims & Hers selloff
Hims & Hers missed third-quarter earnings expectations, reported subscriber declines and sharply lower gross margins, then cut its profit outlook. Those results signal that branded weight-loss products and marketing changes are pressuring profitability, providing a clear explanation for the 16.52% share-price drop.
earnings and guidancehigh confidence
Sources 13
- Hims & Hers Health: Don't Nitpick Quarterly Resultsseekingalpha.com
- HIMS Q3 Earnings Call Highlights Marketing Reset and Margin Pressurefinance.yahoo.com
- Hims & Hers Drops 18% as Q3 Loss and Profit Outlook Cut Disappoint; Novo Nordisk Slides 2%, Eli Lilly Holds Steady247wallst.com
- Hims & Hers Celebrated Its Eli Lilly Deal, Then Lost a Quarter of Its Value in a Week247wallst.com
- Hims & Hers Health slides 14% after earnings miss, guidance cutseekingalpha.com
- JPMorgan cuts Hims and Hers stock price target on subscriber decline - Investing.comnews.google.com
- Why Is Hims & Hers Health (HIMS) Bringing Andrew Huberman Onto Its Board?finnhub.io
- Hims & Hers Stocks Plunge 15.37% as Margin Squeeze Forces EBITDA Guidance Cutfinnhub.io
- Hims & Hers Drops 18% as Q3 Loss and Profit Outlook Cut Disappoint; Novo Nordisk Slides 2%, Eli Lilly Holds Steadyfinnhub.io
- Hims & Hers Drops 18% as Wall Street Loses Patiencefinnhub.io
- Hims & Hers Celebrated Its Eli Lilly Deal, Then Lost a Quarter of Its Value in a Weekfinnhub.io
- Hims & Hers Health Inc (HIMS) (Q3 2026) Earnings Call Highlights: Revenue Surges 49% to ...finnhub.io
- HIMS May See Heightened ‘Gyrations’ As Weight-Loss Drug Trends Fuel Subscriber Uncertainty, Jefferies Warns – Stock Hits 7-Month Lowsfinnhub.io
Our call
Sell somedated Nov 11, 2026
Hims & Hers Health fell 22% over the past four trading days after its Nov 9 report missed profit forecasts by 57%, and it sits 48% below its high of the past year. We'd look again if Hims & Hers Health's next report beats profit forecasts.
Other moves on Nov 10
- LFVN−13.6%LifeVantage Stock Falls After Revenue Drops 22%
- QLYS−13.3%Qualys Falls Despite Earnings Beat on Tepid Revenue Outlook
- ACAD+10.7%Revenue Beat and Guidance Lift Acadia Shares
- ASTS−8.7%AST SpaceMobile slides after earnings miss and price-target cut
- BDSX−8.5%Analyst trims Biodesix target despite maintaining Buy rating
- SERV−8.4%Analyst lowers Serve Robotics price target, pressuring shares